Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?
- 2 February 2006
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 32 (2), 188-202
- https://doi.org/10.1007/s00134-005-0044-y
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Filter Run Time in CVVH: Pre- versus Post-Dilution and Nadroparin versus Regional Heparin-Protamine AnticoagulationBlood Purification, 2005
- Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney diseaseAmerican Journal of Kidney Diseases, 2004
- Author Index for AbstractsBlood Purification, 2003
- The Acute Dialysis Quality Initiative—Part VI: Access and anticoagulation in CRRTAdvances in Renal Replacement Therapy, 2002
- A NOVEL METHOD FOR REGIONAL CITRATE ANTICOAGULATION IN CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVHF)Renal Failure, 2002
- Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltrationIntensive Care Medicine, 1996
- Heparin clearance during continuous veno-venous haemofiltrationIntensive Care Medicine, 1994
- Anticoagulant regimens in acute continuous hemodiafiltration: a comparative studyIntensive Care Medicine, 1993
- Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patientsKidney International, 1990
- Cultured human endothelial cells generate tissue factor in response to endotoxin.Journal of Clinical Investigation, 1983